Instructional Course - Requires Course Pass or Individual Course Ticket, Additional Registration Required
Stephen Boorjian, MD
Mayo Clinic
.jpg "Daniel Barocas, MD photo")
Daniel Barocas, MD
Vanderbilt University Medical Center
Jay Raman, MD
Professor and Chief
Penn State Health Milton S. Hershey Medical Center
Hematuria is one of the most common indications for urologic evaluation, and is recognized as a sign of potentially important illness. Therefore, knowledge of the differential diagnosis, principles of evaluation, and strategies for management of hematuria is critical. This course is designed for the practicing urologist, to provide a guidelines-based and case-oriented approach to the evaluation and management of hematuria. Specifically, after attending the course, participants will understand the guideline recommendations for the initial evaluation of patients with asymptomatic microscopic hematuria, as well as the evidence supporting these recommendations. Recommendations for follow-up of these patients will also be covered. In addition, the course will cover the initial and follow-up evaluation for patients presenting with symptomatic microscopic hematuria and gross hematuria. The course will also include a practical, case-based presentation of frequently-encountered clinical management challenges, particularly for refractory hemorrhagic cystitis and persistent BPH-related bleeding. Detailed information will be provided regarding intravesical treatment regimens and associated side effect profiles. Additionally, data will be reviewed supporting treatments for refractory disease, including hyperbaric oxygen and selective angioembolization.